Integrated Clinical Systems, Inc.
- UEI
- FFV9ACR6P5M5
- CAGE
- 4SPQ2
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 513210 Software Publishers Primary
- SAM.gov registration date
- Website
- i-review.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Software | National Cancer Institute | $24,996 | |
| Software renewal | National Cancer Institute | $24,996 | |
| Integrated clinical systems, INC:1124145 [23-012540] jreview enhancement for study data collected in C3D and medidata… | National Cancer Institute | $17,000 | |
| Software renewal | National Cancer Institute | $24,996 | |
| Software renewal | National Cancer Institute | $24,996 |
About Integrated Clinical Systems, Inc.
Integrated Clinical Systems, Inc. is a for-profit Subchapter S corporation located in Frenchtown, New Jersey, specializing in software solutions for clinical trial monitoring and data management. Registered in SAM.gov since 2007, the company develops specialized software platforms like JReview that support risk-based monitoring and analytics for biomedical research environments. The company appears to focus on providing technical software solutions and support services to federal health research agencies, with a particular emphasis on clinical trial data management and analysis tools.
The company has received federal contract awards primarily from the National Cancer Institute and the Food and Drug Administration, consistently providing software licensing, maintenance, and enhancement services. Their most significant contract was a $1,041,875 delivery order with the FDA's Center for Drug Evaluation and Research from August 2020 through September 2022, supporting pre-market application review activities. Subsequent contracts have been smaller purchase orders, typically ranging from $17,000 to $25,000, focused on software renewals and enhancements for JReview software. All of the company's federal contract awards have been firm fixed-price contracts without specific set-aside designations, and they have consistently worked directly as a prime contractor providing technical software services to federal health research agencies. The contracts demonstrate a specialized niche in supporting clinical research data management through custom software solutions.
SBA capabilities narrative
JReview
Quick answers
What is Integrated Clinical Systems, Inc.'s UEI?
Integrated Clinical Systems, Inc.'s Unique Entity ID (UEI) in SAM.gov is FFV9ACR6P5M5.
What is Integrated Clinical Systems, Inc.'s CAGE code?
Integrated Clinical Systems, Inc.'s CAGE code is 4SPQ2.
What is Integrated Clinical Systems, Inc.'s primary NAICS code?
Integrated Clinical Systems, Inc.'s primary NAICS code is 513210 (Software Publishers).
Is Integrated Clinical Systems, Inc. registered in SAM.gov?
Integrated Clinical Systems, Inc.'s SAM.gov registration expired on July 29, 2026.
What is Integrated Clinical Systems, Inc.'s most recent federal award?
Integrated Clinical Systems, Inc.'s most recent federal contract award is Software (75N91024P00554), from National Cancer Institute, on July 1, 2024.
On GovTribe
See Integrated Clinical Systems, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors